Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Moving Target

Moving Target

posted on Jan 06, 2008 08:54AM

 From what I've read lately. Dutton has issued a new adjusted ' lower' target. This comes after exceeding their target of .92 cents intraday during December.

  Should we care a great deal what Dutton says ?

  While they do raise interesting points for their reasoning. They constantly forget to see the big picture of an extremely qualified product that has time and again been proven valid. Every barrier that the patents have come against have fallen, thus far. The remaining obstacles are mere 'speed bumps' compared to the mountainous climbs the patents have conquered.

  Duttons' targets have made every 'long ' smirk with each publication of an adjustment. More importantly, each of their adjustments have been exceeded.
  Dutton has a cautious attitude and there is no reason to admonish them for such. I do however consider it annoying when they ignore that PTSC has gone from debters prison to a concensus 50 + million in the bank. Money doesn't grow on trees, theres' a reason and I wish they would pay more attention to this rather obvious rapid growth.

  Long & Strong

Share
New Message
Please login to post a reply